
Doctor Valeria Paradies
Maasstad Hospital, Rotterdam (Netherlands (The))
Membership:
ESC Professional Member
EAPCI Member
Biography
Valeria Paradies is an interventional cardiologist, head of research department and cathlab co-director at Maasstad Hospital (Rotterdam, the Netherlands). She completed her medical degree cardiology training in Italy, an interventional cardiology fellowship training in Rotterdam and a clinical research fellowship at National Heart Centre in Singapore where she also acquired expertise in cardiac magnetic resonance (CMR). She achieved the degree of Master of Clinical Science in structural heart intervention at University of Padova and she is currently enrolled in a PhD program at Erasmus Medical Centre University in Rotterdam.
She is the PI of the Compare STEMI One RCT and is currently the local PI of more 10 RCTs at her centre and the author of 84 papers published in peer-reviewed journals. She is actively involved in the EuroPCR course, European Bifurcation Club and in the organisms under the umbrella of the European Association of Percutaneous Cardiovascular Interventions, currently.
Contributor content
Session
Live-in-the-box: high-risk PCI in HFrEF - intracoronary imaging for calcified coronary lesions
20 February 2026
Session
EAPCI Calcified Lesions 360°: calcium modification tools
20 February 2026
Session
Workshop - EAPCI how to: orbital
10 October 2025
Session
Workshop - Hands-on complication management - no-reflow
10 October 2025
Session
The QUIZtory of cardiology
1 September 2025
Session
Challenges in the implementation of therapies for long-term management in coronary artery disease
31 August 2025
Session
Coronary physiology and microcirculatory assessment
31 August 2025
Session
Optical coherence tomography and cardiovascular risk assessment
30 August 2025
Session
All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics
2 September 2024
Session
Possible shifts in paradigms for lipid-lowering therapies in acute coronary syndrome patients
2 September 2024

